Search

everythinglearnresearchcommunity

for

Search:↓

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

PCOS affects many women, causing various symptoms and health risks, and is managed through lifestyle changes, medication, and support groups.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.